Results 1 to 10 of about 15,392,732 (265)
Lipopeptides for Vaccine Development [PDF]
Bioconjugate Chemistry, 2021 The development of lipopeptides (lipidated peptides) for vaccines is discussed, including their role as antigens and/or adjuvants. Distinct classes of lipopeptide architectures are covered including simple linear and ligated constructs and lipid core peptides.
openaire +3 more sources
Peptides for Vaccine Development [PDF]
ACS Applied Bio Materials, 2022 This review discusses peptide epitopes used as antigens in the development of vaccines in clinical trials as well as future vaccine candidates. It covers peptides used in potential immunotherapies for infectious diseases including SARS-CoV-2, influenza, hepatitis B and C, HIV, malaria, and others.
openaire +2 more sources
COVID-19 Vaccine Development to Vaccination
Journal of Nepal Health Research Council, 2021 In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey +2 more
openaire +2 more sources
Transforming Vaccine Development
Seminars in Immunology, 2020 The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines which are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine ...
Steve Black +4 more
openaire +4 more sources
BMJ, 2002 Vaccines are hailed as one of the most important public health achievements of the 20th century.1 In the next five to 15 years, new vaccines and new vaccine delivery technology will fundamentally change how clinicians prevent and treat disease, with a substantial impact on public health.
Gregory A, Poland +2 more
openaire +2 more sources
Chikungunya vaccines in development [PDF]
Human Vaccines & Immunotherapeutics, 2015 Chikungunya virus has become a global health threat, spreading to the industrial world of Europe and the Americas; no treatment or prophylactic vaccine is available. Since the late 1960s much effort has been put into the development of a vaccine, and several heterogeneous strategies have already been explored.
Schwameis, Michael +4 more
openaire +2 more sources
Nanoparticles and Vaccine Development
Pharmaceutical Nanotechnology, 2020 In spite of the progress of conventional vaccines, improvements are required due to concerns about the low immunogenicity of the toxicity, instability, and the need for multiple administrations of the vaccines. To overcome the mentioned problems, nanotechnology has recently been incorporated into vaccine development.
Mehdi kheirollahpour +4 more
openaire +2 more sources
Development of a schistosomiasis vaccine [PDF]
Expert Review of Vaccines, 2016 Schistosomiasis is a neglected tropical disease (NTD) of public health importance. Despite decades of implementation of mass praziquantel therapy programs and other control measures, schistosomiasis has not been contained and continues to spread to new geographic areas.
Adebayo J, Molehin +5 more
openaire +2 more sources
The Lancet, 2004 Large gains in the reduction of malaria mortality in the early 20th century were lost in subsequent decades. Malaria now kills 2-3 million people yearly. Implementation of malaria control technologies such as insecticide-treated bednets and chemotherapy could reduce mortality substantially, but an effective malaria vaccine is also needed.
Moorthy, V, Good, M, Hill, A
openaire +3 more sources
Development of Varicella Vaccine [PDF]
The Journal of Infectious Diseases, 2008 The Oka strain of varicella-zoster virus (VZV) was first isolated from vesicles of an otherwise healthy 3-year-old boy with typical varicella. The virus was passaged 11 times in human embryonic lung fibroblasts at 34 degrees C and 12 times in guinea pig embryo fibroblasts (GPEFs) at 37 degrees C.
Michiaki, Takahashi +6 more
openaire +2 more sources